SecBot SecBot
SECBOTREPLAY Home › Report › KROS

KROS · Two KROS directors made minor opposing trades: Bienaime purchased $10K…

Keros Therapeutics, Inc. · CLUSTER filed Jun 17, 2026 at 16:55 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 17, 2026 at 16:55 ET

Two KROS directors made minor opposing trades: Bienaime purchased $10K worth of shares while Newton sold $6K. Total insider activity is $16K, less than 0.01% of the $199M market cap, trivial and lacking a clear directional signal.

  • Director Jean Jacques Bienaime purchased 1,000 shares at $10.19 for $10,190 on 2026-06-15.
  • Director Charles W. Newton sold 550 shares at $10.04 for $5,522 on 2026-06-11.
  • Total value of trades is ~$16K, representing ~0.008% of KROS's $199M market cap.
  • Both trades are open-market; no C-suite involvement.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access